Overview Request Sample Pages Request Customization Download PDF
You are viewing: Canada Veterinary Biologics Market analysis
Part of: Veterinary Biologics Market (Global)

The Canada Veterinary Biologics Market was valued at $62.87 Million in 2025 and projected to reach to $80.77 Million by 2030, representing a compound annual growth rate of 5.1%. Canada's veterinary biologics market is positioned for steady growth through 2030, supported by the country's strong agricultural foundation and increasing investment in animal health innovation.

Canada Veterinary Biologics Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Canada Veterinary Biologics Market Trends and Insights

  • This steady expansion reflects Canada's robust livestock and companion animal sectors, coupled with increasing adoption of advanced biological therapeutics across veterinary practices.
  • Canada's market growth is driven by rising awareness of preventive healthcare in animals, stringent regulatory standards that favor quality biologics, and growing investment in animal health infrastructure across the country. The Canadian veterinary biologics landscape is characterized by a mature healthcare system and strong regulatory oversight through Health Canada and the Canadian Food Inspection Agency.
  • Canada's market benefits from high pet ownership rates, significant dairy and beef cattle operations, and a well-established distribution network for veterinary pharmaceuticals.
  • Between 2025 and 2030, Canada is expected to see increased demand for immunological products, vaccines, and therapeutic biologics as veterinarians and animal owners prioritize disease prevention and treatment efficacy..

Key Market Statistics

  • CAGR (2025-2030) 5.1% CAGR
  • Market Size, 2025 ~USD 62.87 Million
  • Forecast, 2030 ~USD 80.77 Million
  • Country Canada

Canada Veterinary Biologics Market Overview

Market Valuation :

Canada's veterinary biologics market is valued at $62.87 million in 2025, with projections reaching $80.77 million by 2030, demonstrating consistent market expansion.

Steady Growth Trajectory :

The Canadian market exhibits a CAGR of 5.1% from 2025 to 2030, slightly below the global average of 5.2%, reflecting stable but measured growth in the region.

Livestock and Companion Animal Sectors :

Canada's robust livestock industry and thriving companion animal sector drive demand for advanced biological therapeutics, supporting market expansion across multiple veterinary segments.

Adoption of Advanced Biologics :

Increasing adoption of advanced biological therapeutics across Canadian veterinary practices reflects growing awareness of efficacy and improved animal health outcomes in the region.

Canada Veterinary Biologics Market Dynamics

  • The adoption of advanced biological therapeutics is accelerating as Canadian veterinarians recognize the clinical and economic benefits of these solutions for both livestock and companion animals.
  • Regulatory support and favorable reimbursement policies further enhance market conditions. The Canadian market will benefit from rising consumer awareness regarding preventive animal healthcare and the growing prevalence of zoonotic diseases.
  • Strategic partnerships between domestic and international biologics manufacturers, combined with enhanced distribution networks across provinces, will facilitate market penetration.
  • Continued investment in veterinary research and development will drive innovation and expand the therapeutic applications of biologics in Canada..

Related Ecosystem

Animal Health

Top Technologies
  • Polymerase Chain Reaction (PCR) Tests
  • Porcine
  • Immunodiagnostics
  • Lateral Flow Assays
  • Microarrays
Top Companies
  • Zoetis Inc.
  • Patterson Companies, Inc.
  • Virbac
  • Elanco Animal Health Incorporated
  • BOEHRINGER INGELHEIM GMBH

    Key Takeaways

    • Canada's veterinary biologics market is valued at $62.87 million in 2025 and will reach $80.77 million by 2030, growing at 5.1% CAGR.
    • Canada's market is supported by high pet ownership, substantial livestock operations, and stringent regulatory frameworks that ensure product quality.
    • Preventive healthcare adoption and disease management awareness are key growth drivers in Canada's veterinary biologics sector.
    • Canada's mature distribution infrastructure and strong regulatory oversight position the country as a stable market for veterinary biological products.

    Veterinary Biologics Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment CANINE (Type)
    Forecast Period 2025–2030
    Growth Rate CAGR of 5.2% from 2025 to 2030
    Largest Segment INJECTABLE ROUTE OF ADMINISTRATION (Route Of Administration)
    Market Size Base Year (Billions) ~USD 2.72 (2025)
    Revenue Forecast (Billions) ~USD 3.51 (2030)
    Segments Covered Product Type, Animal Type, Type, Route Of Administration, Application, End User

    Canada Veterinary Biologics Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Product Type

    • Diagnostic Kits
    • Immunodmodulators & Immunostimulants
    • Immunoglobulins & Antitoxins
    • Immunomodulators & Immunostimulants
    • Immuoglobulins & Antitoxins
    • Monoclonal Anitbodies
    • Monoclonal Antibodies

    By Animal Type

    • Companion Animal
    • Companion Animals
    • Livestock Animal
    • Livestock Animals

    By Type

    • Bovine
    • Canine
    • Equine
    • Feline
    • Intramuscular Route Of Administration
    • Intravenous Route Of Administration
    • Other Injectable Route Of Administration
    • Porcine
    • Poultry
    • Small Ruminant
    • Subcutaneous Route Of Administration

    By Route Of Administration

    • Injectable Route Of Administration
    • Oral Route Of Administration
    • Other Routes Of Administration

    By Application

    • Dermatology
    • Diagnostic Testing
    • Diagnostic Tetsing
    • Infectious Disease Prevention
    • Oncology
    • Other Applications
    • Pain Management

    By End User

    • Other End Users
    • Veterinary Diagnostic Labs
    • Veterinary Hospitals & Clinics

    CANADA: VETERINARY BIOLOGICS MARKET, BY END USER, 2023–2030

    Segment20232024202520262027202820292030CAGR (%)
    OTHER END USERS4.084.164.244.344.464.584.734.892.9
    VETERINARY DIAGNOSTIC LABS23.9824.6125.3126.1126.9827.9729.0930.283.7
    VETERINARY HOSPITALS & CLINICS62.8565.5168.4571.7275.379.2983.7688.565.3
    TOTAL90.9194.2898102.17106.74111.84117.58123.724.8

    Target Audience

    • Veterinary Biologics Manufacturers : Manufacturers need Canada-specific market data to assess market size, growth potential, and competitive dynamics for product launches, expansion strategies, and resource allocation decisions.
    • Pharmaceutical & Biotech Companies : Companies evaluating geographic expansion require detailed Canadian market insights to identify entry opportunities, understand regulatory pathways, and forecast revenue potential in the region.
    • Veterinary Practice Operators : Practice owners and managers need market intelligence to understand treatment trends, biologics adoption rates, and investment opportunities in advanced therapeutics for their Canadian operations.
    • Investment & Private Equity Firms : Investors analyzing the Canadian veterinary sector require market-specific data to evaluate acquisition targets, assess growth prospects, and make informed funding decisions in animal health.
    • Regulatory & Policy Advisors : Regulatory consultants and policy makers need Canadian market data to understand industry trends, inform healthcare policies, and support evidence-based decision-making for veterinary biologics.

    Key Companies in the Canada Veterinary Biologics Market

    CompanyHQOwnershipStrongest segments
    IDEXXUnited StatesPublic CompanyCompanion Animal Group (in-clinic diagnostics, reference labs, services, software),Water Quality Products,Livestock, Poultry and Dairy (including related diagnostics),
    ELANCOUnited StatesPublic CompanyCompanion animal parasiticides (Seresto, K-9 Advantage, Advantix, Advocate, Credelio Family, Interceptor Plus, Drontal),Companion animal vaccines and therapeutics (Galliprant, Atopica, Milbemax, Onsior, Tru Family),Farm animal feed additives and productivity enhancers (Rumensin, Experior, Hemicell, Surmax, Pulmotil),
    MERCK & CO., INC.United StatesPublic CompanyOncology (Keytruda, Keytruda Qlex, Welireg, ADC collaborations),Vaccines (Gardasil, pediatric and adult vaccines including Vaxneuvance, Capvaxive),Cardiovascular, pulmonary hypertension and specialty (Winrevair, Adempas/Verquvo, Ohtuvayre, others),
    THERMO FISHER SCIENTIFIC INC.United StatesPublic CompanyLife Sciences Solutions,Analytical Instruments,Specialty Diagnostics,
    NEOGEN CORPORATIONUnited StatesPublic CompanyFood Safety diagnostics, media, and sanitation,Animal Safety instruments, care products, and biosecurity,Genomics services for livestock and companion animals,
    BIO-RAD LABORATORIES, INC.United StatesPublic CompanyClinical Diagnostics,Life Science Research Instruments and Systems,Life Science Reagents and Consumables,
    IMMUCELL CORPORATIONUnited StatesPublic CompanyFirst Defense (core scours prevention),Tri-Shield First Defense,Dual-Force First Defense and related formulations,

    IDEXX

    IDEXX is a public company founded in 1983 and headquartered in the United States, employing 11,000 people.

    ELANCO

    Elanco is a public company founded in 1954 in the United States with 9,650 employees.

    MERCK & CO., INC.

    Merck & Co., Inc. is a public pharmaceutical company founded in 1891 and based in the United States, with 74,000 employees.

    THERMO FISHER SCIENTIFIC INC.

    Thermo Fisher Scientific Inc. is a public company founded in 1956 in the United States and employs 125,000 people.

    NEOGEN CORPORATION

    Neogen Corporation is a public company founded in 1981 in the United States with 2,974 employees.

    BIO-RAD LABORATORIES, INC.

    Bio-Rad Laboratories, Inc. is a public company founded in 1952 in the United States and employs 7,450 people.

    IMMUCELL CORPORATION

    ImmuCell Corporation is a public company founded in 1982 in the United States with 73 employees.

    Reasons to Buy this Report

    • Market-Specific Sizing & Forecasts : Access precise valuation data for Canada's veterinary biologics market with detailed 2025-2030 projections, enabling accurate business planning and investment decisions tailored to the Canadian landscape.
    • Regional Growth Drivers Analysis : Understand the unique factors propelling Canada's 5.1% CAGR, including livestock sector dynamics, companion animal trends, and adoption patterns specific to Canadian veterinary practices.
    • Competitive Landscape Intelligence : Identify market opportunities and competitive positioning within Canada's $62.87 million market, with insights into regional distribution channels and veterinary practice preferences.
    • Regulatory & Market Environment : Gain insights into Canada's favorable regulatory framework, reimbursement policies, and provincial healthcare dynamics that influence veterinary biologics adoption and market expansion.
    • Strategic Market Entry Planning : Develop informed go-to-market strategies for Canada with localized data on customer segments, geographic hotspots, and growth opportunities across livestock and companion animal sectors.

    Frequently asked questions

    What is the current size of Canada's veterinary biologics market?

    Canada's veterinary biologics market is valued at $62.87 million in 2025 and is expected to grow to $80.77 million by 2030.

    What is the growth rate of Canada's veterinary biologics market?

    Canada's veterinary biologics market is growing at a compound annual growth rate (CAGR) of 5.1% from 2025 to 2030.

    What factors are driving growth in Canada's veterinary biologics market?

    Growth in Canada is driven by increased pet ownership, expanding livestock operations, rising awareness of preventive animal healthcare, and stringent regulatory standards that favor high-quality biological products.

    Which regulatory bodies oversee veterinary biologics in Canada?

    Health Canada and the Canadian Food Inspection Agency (CFIA) are the primary regulatory bodies overseeing veterinary biologics approval and compliance in Canada.

    What types of veterinary biologics are most in demand in Canada?

    Canada shows strong demand for vaccines, immunological products, and therapeutic biologics used in both companion animal and livestock sectors for disease prevention and treatment.

    RESEARCH METHODOLOGY

    This study extensively used both primary and secondary sources. The research process examined various factors affecting the industry to identify segmentation types, industry trends, key players, competitive landscape, market dynamics, and strategies of major players.

    Secondary Research

    This research involved the use of comprehensive secondary sources, including directories; databases such as Bloomberg Business, Factiva, and Dun & Bradstreet; white papers; annual reports; company house documents; investor presentations; and SEC filings of companies. Secondary research was employed to gather information for an extensive, technical, market-focused, and commercial analysis of the veterinary biologics market. It also helped obtain crucial details about key players, market classification, and segmentation based on industry trends at the most detailed levels, as well as significant developments related to market and technology perspectives. Additionally, a database of major industry leaders was created using secondary research.

    Primary Research

    In the primary research process, various sources from both the supply and demand sides were interviewed to gather qualitative and quantitative information for this report. Primary sources from the supply side include project managers, sales managers, marketing managers, business development managers, presidents, CEOs, vice presidents, chairpersons, chief operating officers, chief strategy officers, directors, chief information officers, and chief medical information officers related to the veterinary biologics market. Primary sources from the demand side consist of professionals from veterinary hospitals and clinics, diagnostic labs, academic and research institutes, and pet owners.

    A breakdown of the primary respondents is provided below:

    Veterinary Biologics Market

    Note 1: C-level primaries include CEOs, CFOs, COOs, and VPs.

    Note 2: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

    Note 3: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = < USD 1.00 billion.

    Source: MarketsandMarkets Analysis

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The total size of the veterinary biologics market was determined through data triangulation from three different approaches, as outlined below. After each approach, a weighted average was calculated based on the level of assumptions used in each method.

    Veterinary Biologics Market

    Data Triangulation

    After defining the market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown methods were used where applicable to complete the overall market analysis and determine accurate statistics for all segments and subsegments. The following figure illustrates the market validation, source structure, and data triangulation approach used in the market analysis process.

    Market Definition

    The veterinary biologics market includes all USDA-regulated biologic products, such as monoclonal antibodies, immunoglobulins, immunomodulators, and diagnostic kits, which are used for the prevention, diagnosis, or treatment of animal diseases. These products serve companion animals, livestock, and poultry across veterinary clinics, hospitals, diagnostic labs, and farm or herd settings, enabling veterinarians and animal health professionals to provide targeted immune-based interventions and rapid diagnostic testing. This allows infected animals to be identified quickly for faster treatment, containment, or herd management decisions.

    Stakeholders

    • Veterinary Biologics Manufacturers
    • Animal Healthcare Product Manufacturers
    • Veterinary Biologics Distributors and Wholesalers
    • Animal Welfare Associations
    • Veterinary Clinics and Care Centers
    • Research And Consulting Firms
    • Veterinary Research and Development Organizations
    • Contract Manufacturing Organizations
    • Venture Capitalists

    Report Objectives

    • To define, describe, and forecast the veterinary biologics market by product type, animal type, route of administration, application, end user, and region.
    • To provide detailed information about the key factors, such as drivers, restraints, opportunities, challenges, and industry trends, influencing the market growth
    • To strategically analyze the regulatory scenario, value chain analysis, supply chain analysis, Porter’s Five Forces analysis, ecosystem analysis, trade analysis, pricing analysis, patent analysis, impact of AI on veterinary biologics market, case study analysis, adjacent market analysis, unmet needs/end user expectations in veterinary biologics market, and trends/disruption impacting customer business in the market
    • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
    • To strategically analyze the market in five regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To strategically profile the key players in this market and comprehensively analyze their market shares and core competencies
    • To track and analyze competitive developments such as product launches and approvals, partnerships, and expansions in the market

     

    Get the Full Veterinary Biologics Market Report

    Full forecast, segment splits, and company analysis for all Veterinary Biologics Market.

    Download Sample Pages Buy Report

    METHODOLOGY

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    Cite this Research
    DMCA.com Protection Status